Donald Trump’s election has unleashed hope for dealmaking, regulatory easing, and private credit, all of which should help out Goldman Sachs (GS), Telis Demos of The Wall Street Journal reports. Goldman would benefit from an uptick in merger-and-acquisition or initial-public-offering activity, as well as any regulatory rollback. Additionally, Goldman may have the potential to win big from growth in private credit and alternative assets, specifically. Private credit may be set to benefit under Trump, since new securities regulators may be less inclined to limit the availability of relatively illiquid private-credit investments to everyday investors and rising Treasury yields could benefit the sector.
Don't Miss our Black Friday Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GS:
- Pfizer Considers Selling Hospital Unit to Free Up Cash and Reduce Debt
- Pfizer said to be exploring sale of hospital drugs unit, Reuters reports
- Insider Trading: Goldman’s (GS) Key Insiders Sell Stock Worth $13.3M Post Trump-Led Rally
- Trump’s Victory Sparks Market Surge: The Winners and Losers of the “Trump Trade”
- Here’s what Wall Street is saying about Qualcomm ahead of earnings